Possible benefit of oral alitretinoin in T-lymphoproliferative diseases: a report of two patients with palmoplantar hyperkeratotic-rhagadiform skin changes and mycosis fungoides or Sézary syndrome.
Molin
S
S
Ruzicka
T
T
D000368:Aged; D000077556:Alitretinoin; D000970:Antineoplastic Agents / Q000008:administration & dosage*; D006801:Humans; D007645:Keratoderma, Palmoplantar / Q000628:therapy*; D008297:Male; D009182:Mycosis Fungoides / Q000628:therapy*; D017893:Photopheresis; D012751:Sezary Syndrome / Q000628:therapy*; D012878:Skin Neoplasms / Q000628:therapy*; D016896:Treatment Outcome; D014212:Tretinoin / Q000008:administration & dosage*
D000970:Antineoplastic Agents; D000077556:Alitretinoin; D014212:Tretinoin